Tag: neurotoxin

All

FDA Accepts Application for Botox to Treat Masseter Muscle Prominence

If approved, the neurotoxin would be the first indicated for the temporary improvement of marked to very marked masseter muscle prominence in the United States.

DelNova Shows First Human Neurotoxin Muscle Weakness Reversal
2024’s Biggest Facial Plastic Surgery Trends
New Short-Term Botox-Like Treatment Moves Closer to FDA Review
Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E
Allergan Aesthetics Presents New Data on Facial Injectable Portfolio at IMCAS 2026
FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
Allergan Aesthetics Presents Data on Investigational Neurotoxin and GLP-1 Patient Trends
New Dashboard Tracks How Aesthetic Patients Combine Treatments and Products

All

Hugel Aesthetics Expands US Support for Letybo With Direct Sales Force

The company is building a dedicated sales and medical affairs team to drive adoption of its neurotoxin and provide practices with direct clinical and commercial support.